Victor Perlroth
Vermögen: 110 Mio $ am 31.05.2026
Vermögen: 110 Mio $ am 31.05.2026
Victor Perlroth ist Gründer von Kodiak Sciences, Inc. und Avidia, Inc. und bekleidet die Position des Chairman & Chief Executive Officer bei Kodiak Sciences, Inc. Zuvor war Dr. Perlroth als Chief Operating Officer bei Guzik Technical Enterprises, Inc., als Venture Partner bei MPM Capital Inc. und als General Manager bei Avidia, Inc. tätig. Dr. Perlroth erhielt einen Undergraduate-Abschluss von der Princeton University und einen MBA sowie einen Doktortitel von der Stanford University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KODIAK SCIENCES, INC. 4,79 % | 31.03.2026 | 2.995.038 ( 4,79 % ) | 110 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| KODIAK SCIENCES INC. | Vorstandsvorsitzender | 01.01.2009 |
| Unternehmen | Position | Ende |
|---|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 31.12.2008 |
Avidia, Inc.
Avidia, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Gründer | 28.02.2007 |
Guzik Technical Enterprises, Inc.
Guzik Technical Enterprises, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures & provides magnetic head & test equipment to disk drive | Geschäftsführer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Avidia, Inc.
Avidia, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guzik Technical Enterprises, Inc.
Guzik Technical Enterprises, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures & provides magnetic head & test equipment to disk drive | Electronic Technology |
Kodiak Sciences, Inc.
Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen